Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

AZTR

Azitra (AZTR)

Azitra Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:AMEX:AZTR
日付受信時刻ニュースソース見出しコード企業名
2024/09/1822 : 00Business WireAzitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
2024/09/1706 : 47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:AZTRAzitra Inc
2024/09/0705 : 30Business WireAzitra to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:AZTRAzitra Inc
2024/08/2821 : 30Business WireAzitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
2024/08/2222 : 00Business WireAzitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
2024/08/2105 : 15Business WireAzitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
2024/08/1307 : 23Business WireAzitra, Inc. Announces Q2 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
2024/08/1306 : 15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
2024/08/1306 : 02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
2024/08/0305 : 05Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:AZTRAzitra Inc
2024/07/3005 : 01Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AZTRAzitra Inc
2024/07/2705 : 05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
2024/07/2606 : 57Business WireCORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public OfferingAMEX:AZTRAzitra Inc
2024/07/2603 : 15Business WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
2024/07/2519 : 03Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
2024/07/2413 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AZTRAzitra Inc
2024/07/2410 : 20Business WireAzitra, Inc. Announces Pricing of $10.0 Million Public OfferingAMEX:AZTRAzitra Inc
2024/07/2321 : 00Business WireAzitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed PatentsAMEX:AZTRAzitra Inc
2024/07/2006 : 27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:AZTRAzitra Inc
2024/07/1606 : 11Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AZTRAzitra Inc
2024/07/1519 : 21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AZTRAzitra Inc
2024/07/0913 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AZTRAzitra Inc
2024/06/2805 : 05Business WireAzitra, Inc. Announces Reverse Stock SplitAMEX:AZTRAzitra Inc
2024/06/0405 : 30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
2024/05/3121 : 00Business WireAzitra, Inc. Announces Presentation at the 2024 BIO International ConventionAMEX:AZTRAzitra Inc
2024/05/2505 : 55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AZTRAzitra Inc
2024/05/1721 : 00Business WireAzitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual MeetingAMEX:AZTRAzitra Inc
2024/05/1021 : 00Business WireAzitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual MeetingAMEX:AZTRAzitra Inc
2024/05/1006 : 05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
2024/05/1006 : 03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

最近閲覧した銘柄